Negative for intraepithelial lesion or malignancy - Revision history

Michael at 20:26, 22 September 2015

2015-09-22T20:26:28Z

← Older revision		Revision as of 20:26, 22 September 2015
Line 6:		Line 6:
	NILM does not exclude the presence of other findings, e.g. [[candida]].<ref>{{Cite journal \| last1 = Moriarty \| first1 = AT. \| last2 = Darragh \| first2 = TM. \| last3 = Fatheree \| first3 = LA. \| last4 = Souers \| first4 = R. \| last5 = Wilbur \| first5 = DC. \| title = Performance of Candida--fungal-induced atypia and proficiency testing: observations from the College of American Pathologists proficiency testing program. \| journal = Arch Pathol Lab Med \| volume = 133 \| issue = 8 \| pages = 1272-5 \| month = Aug \| year = 2009 \| doi = 10.1043/1543-2165-133.8.1272 \| PMID = 19653724 }}</ref>		NILM does not exclude the presence of other findings, e.g. [[candida]].<ref>{{Cite journal \| last1 = Moriarty \| first1 = AT. \| last2 = Darragh \| first2 = TM. \| last3 = Fatheree \| first3 = LA. \| last4 = Souers \| first4 = R. \| last5 = Wilbur \| first5 = DC. \| title = Performance of Candida--fungal-induced atypia and proficiency testing: observations from the College of American Pathologists proficiency testing program. \| journal = Arch Pathol Lab Med \| volume = 133 \| issue = 8 \| pages = 1272-5 \| month = Aug \| year = 2009 \| doi = 10.1043/1543-2165-133.8.1272 \| PMID = 19653724 }}</ref>

			==Sign out==
			<pre>
			Negative for intraepithelial lesion or malignancy (NILM).
			</pre>
	==See also==		==See also==
	*[[Gynecologic cytopathology]].		*[[Gynecologic cytopathology]].

Michael at 14:55, 24 October 2014

2014-10-24T14:55:31Z

← Older revision		Revision as of 14:55, 24 October 2014
Line 1:		Line 1:
	'''Negative for intraepithelial lesion or malignancy''', abbreviated '''NILM''',<ref>{{Cite journal \| last1 = Sturgis \| first1 = CD. \| last2 = Schaaf \| first2 = MR. \| last3 = Tickman \| first3 = RJ. \| title = Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure. \| journal = Diagn Cytopathol \| volume = 41 \| issue = 5 \| pages = 399-403 \| month = May \| year = 2013 \| doi = 10.1002/dc.22829 \| PMID = 22351303 }}		'''Negative for intraepithelial lesion or malignancy''', abbreviated '''NILM''',<ref>{{Cite journal \| last1 = Sturgis \| first1 = CD. \| last2 = Schaaf \| first2 = MR. \| last3 = Tickman \| first3 = RJ. \| title = Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure. \| journal = Diagn Cytopathol \| volume = 41 \| issue = 5 \| pages = 399-403 \| month = May \| year = 2013 \| doi = 10.1002/dc.22829 \| PMID = 22351303 }}
	</ref> is the common terminology for - both of the following:		</ref> is the common terminology for - both of the following:
	*No [[SIL]] is present.		*No [[Squamous intraepithelial lesion\|squamous intraepithelial lesion (SIL)]] is present.
	*No malignancy is present.		*No malignancy is present.

Michael at 15:34, 26 December 2013

2013-12-26T15:34:42Z

← Older revision		Revision as of 15:34, 26 December 2013
Line 8:		Line 8:
	==See also==		==See also==
	*[[Gynecologic cytopathology]].		*[[Gynecologic cytopathology]].
			*[[Uterine cervix]].

	==References==		==References==

Michael: more

2013-11-24T02:42:27Z

← Older revision		Revision as of 02:42, 24 November 2013
Line 3:		Line 3:
	*No [[SIL]] is present.		*No [[SIL]] is present.
	*No malignancy is present.		*No malignancy is present.

			NILM does not exclude the presence of other findings, e.g. [[candida]].<ref>{{Cite journal \| last1 = Moriarty \| first1 = AT. \| last2 = Darragh \| first2 = TM. \| last3 = Fatheree \| first3 = LA. \| last4 = Souers \| first4 = R. \| last5 = Wilbur \| first5 = DC. \| title = Performance of Candida--fungal-induced atypia and proficiency testing: observations from the College of American Pathologists proficiency testing program. \| journal = Arch Pathol Lab Med \| volume = 133 \| issue = 8 \| pages = 1272-5 \| month = Aug \| year = 2009 \| doi = 10.1043/1543-2165-133.8.1272 \| PMID = 19653724 }}</ref>

			==See also==
			*[[Gynecologic cytopathology]].

	==References==		==References==
	{{Reflist\|1}}		{{Reflist\|2}}

	[[Category:Gynecologic pathology]]		[[Category:Gynecologic pathology]]

Michael: create

2013-11-24T02:37:04Z

create

New page

'''Negative for intraepithelial lesion or malignancy''', abbreviated '''NILM''',<ref>{{Cite journal | last1 = Sturgis | first1 = CD. | last2 = Schaaf | first2 = MR. | last3 = Tickman | first3 = RJ. | title = Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure. | journal = Diagn Cytopathol | volume = 41 | issue = 5 | pages = 399-403 | month = May | year = 2013 | doi = 10.1002/dc.22829 | PMID = 22351303 }}
</ref> is the common terminology for - both of the following:
*No [[SIL]] is present.
*No malignancy is present.

==References==
{{Reflist|1}}

[[Category:Gynecologic pathology]]